ENTA  valuation analysis

Basics
Name: Enanta Pharmaceuticals Inc
Description: Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Nov 22, 2021
Market cap: $1.56B (1126th)
Sales(TTM): $97.07M (1376th)
Earnings(TTM): -$79.00M (1292nd)

Value
FFER: 1.67 (why)
Actual price: $77.36
FFEThis is Enanta Pharmaceuticals Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $46.46
Quantile: ENTA is expensive given its fundamentals.
Prices as of EOD 2021-12-22
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Enanta Pharmaceuticals Inc
"Biotechnology" industry
Sales / MarketCap
Enanta Pharmaceuticals Inc
"Biotechnology" industry
Book / MarketCap
Enanta Pharmaceuticals Inc
"Biotechnology" industry
Equity / Assets
Enanta Pharmaceuticals Inc
"Biotechnology" industry